Evidence map›Paper›PMID 28274268›Full record

Trial reportTrials2017

Acupuncture treatment for insulin sensitivity of women with polycystic ovary syndrome and insulin resistance: a study protocol for a randomized controlled trial.

Juan Li, Ernest Hung Yu Ng, Elisabet Stener-Victorin, Zhenxing Hu, Xiaoguang Shao, Haiyan Wang, Meifang Li, Maohua Lai, Changcai Xie, Nianjun Su and 4 more

Registry-linked trialOpen access · goldFull text readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT02491333. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02491333 phase3completed

The Effect of Acupuncture on Insulin Sensitivity of Women With Polycystic Ovary Syndrome and Insulin Resistance: a Randomized Controlled Trial

Ran2015Enrolled342Registered outcomes12Posted comparisons0ConditionsInsulin Resistance, Polycystic Ovary SyndromeArmsMetformin, placebo metformin, sham acupuncture, true acupuncture
Open the trial in the graph
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Juan LiDepartment of Traditional Chinese Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Ernest Hung Yu NgDepartment of Obstetrics and Gynecology, the University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China.
Elisabet Stener-VictorinDepartment of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
Zhenxing HuDepartment of Gynecology, Xuzhou Maternity & Child Health Hospital, Xuzhou, China.
Xiaoguang ShaoReproductive and Genetic Medical Center, Dalian Municipal Women and Children's Medical Center, Dalian, China.
Haiyan WangReproductive and Genetic Medical Center, Dalian Municipal Women and Children's Medical Center, Dalian, China.
Meifang LiDepartment of Traditional Chinese Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Maohua LaiDepartment of Traditional Chinese Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Changcai XieDepartment of Acupuncture and Moxibustion, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Nianjun SuDepartment of Reproductive Health and Infertility, Guangdong Women and Children Hospital, Guangzhouᅟ, China.
Chuyi YuDepartment of Traditional Chinese Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Jia LiuDepartment of Traditional Chinese Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Taixiang WuChinese Clinical Trial Registry, Beijing, China.
Hongxia MaDepartment of Traditional Chinese Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. doctorhongxia@126.com.
First Affiliated Hospital of Guangzhou Medical University · CNFirst Affiliated Hospital of Guangzhou University of Chinese Medicine · CNGuangdong Province Women and Children Hospital · CNKarolinska Institutet · SEMaternal and Child Health Hospital of Xuzhou · CNUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOur prospective pilot study of acupuncture affecting insulin sensitivity on polycystic ovary syndrome (PCOS) combined with insulin resistance (IR) showed that acupuncture had a significant effect on improving the insulin sensitivity of PCOS. But there is still no randomized controlled trial to determine the effect of acupuncture on the insulin sensitivity in women with PCOS and IR. In this article, we present the protocol of a randomized controlled trial to compare the effect of true acupuncture on the insulin sensitivity of these patients compared with metformin and sham acupuncture. Acupuncture may be an effective therapeutic alternative that is superior to metformin and sham acupuncture in improving the insulin sensitivity of PCOS combined with IR.

methodsThis study is a multi-center, controlled, double-blind, and randomized clinical trial aiming to evaluate the effect of acupuncture on the insulin sensitivity in PCOS combined with IR. In total 342 patients diagnosed with PCOS and IR will be enrolled. Participants will be randomized to one of the three groups: (1) true acupuncture + metformin placebo; (2) sham acupuncture + metformin, and (3) sham acupuncture + metformin placebo. Participants and assessors will be blinded. The acupuncture intervention will be given 3 days per week for a total of 48 treatment sessions during 4 months. Metformin (0.5 g per pill) or placebo will be given, three times per day, and for 4 months. Primary outcome measures are changes in homeostasis model assessment of insulin resistance (HOMA-IR) and improvement rate of HOMA-IR by oral glucose tolerance test (OGTT) and insulin releasing test (Ins). Secondary outcome measures are homeostasis model assessment-β (HOMA-β), area under the curve for glucose and insulin, frequency of regular menstrual cycles and ovulation, body composition, metabolic profile, hormonal profile, questionnaires, side effect profile, and expectation and credibility of treatment. Outcome measures are collected at baseline, at the end of treatments, and 3 months after the last acupuncture treatment. On completion of the screening visit, randomization will be conducted using a central randomization system. DISCUSSION: This study will investigate the effects of acupuncture on the insulin sensitivity of PCOS and IR women compared with metformin and sham acupuncture. We will test whether true acupuncture with needles placed in skeletal muscles and stimulated manually and by electrical stimulation is more effective than metformin and sham acupuncture with superficial needle placement with no manual or electrical stimulation in improving the insulin sensitivity in PCOS women with IR.

trial registrationClinicalTrials.gov, NCT02491333 ; Chinese Clinical Trial Registry, ChiCTR-ICR-15006639. Registered on 24 June 2015.

Indexed as

Acupuncture TherapyInsulin ResistanceAdolescentAdultBiomarkersBlood GlucoseChinaClinical ProtocolsCombined Modality TherapyDouble-Blind MethodFemaleGlucose Tolerance TestHumansHypoglycemic AgentsInsulinMetforminBiomarkersBlood GlucoseHypoglycemic AgentsInsulinMetforminAcupunctureInsulin resistanceMetforminPolycystic ovary syndromeSham acupuncture

Identifiers

PMID28274268
PMCPMC5343367
OpenAlexW2594700260

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.